When stratified by years post-diagnosis, the average annual outpatient cost per patient for SLE showed an increasing trend over time, whereas costs for RA, PsA and AS decreased over time.
← all excerpts
Current landscape of immune-mediated inflammatory rheumatic diseases in Brazil's public and private systems: retrospective cohort study.
1
—
—